Bioactive compounds from a gorgonian coral Echinomuricea sp. (Plexauridae)

Area of Science:

• Marine Natural Products Chemistry
• Organic Chemistry
• Pharmacology

Background:

• Gorgonian corals are a rich source of diverse secondary metabolites.
• The chemical investigation of the genus Echinomuricea is relatively unexplored.
• Marine organisms are increasingly recognized for their unique bioactive compounds.

Purpose of the Study:

• To isolate and characterize novel chemical entities from the gorgonian coral Echinomuricea sp.
• To elucidate the structures of new labdane-type diterpenoids and sterols.
• To evaluate the biological activity of the isolated compounds.

Main Methods:

• Isolation of metabolites using chromatographic techniques.
• Structure elucidation of compounds 1 and 2 via comprehensive spectroscopic analysis (NMR, MS).
• In vitro assays to assess inhibitory effects on superoxide anion generation and elastase release in human neutrophils.

Main Results:

• Discovery and structural determination of echinolabdane A (1), a novel tetracyclic labdane-type diterpenoid with a unique oxepane and α,β-unsaturated-γ-lactone moiety.
• Isolation and identification of 6-epi-yonarasterol B (2), a new sterol derivative.
• Echinolabdane A (1) represents the first labdane-type diterpenoid reported from Cnidaria.
• 6-epi-Yonarasterol B (2) is the first steroid isolated from the genus Echinomuricea and demonstrated significant inhibition of neutrophil inflammatory responses.

Conclusions:

• The gorgonian coral Echinomuricea sp. produces structurally novel natural products.
• Echinolabdane A expands the known structural diversity of labdane diterpenoids in marine organisms.
• 6-epi-Yonarasterol B exhibits promising anti-inflammatory potential, warranting further investigation.